SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection
Given high SARS-CoV-2 incidence, coupled with slow and inequitable vaccine roll-out in many settings, there is a need for evidence to underpin optimum vaccine deployment, aiming to maximise global population immunity. We evaluate whether a single vaccination in individuals who have already been infe...
| Päätekijät: | , , , , , , , , , , , |
|---|---|
| Muut tekijät: | |
| Aineistotyyppi: | Journal article |
| Kieli: | English |
| Julkaistu: |
Springer Nature
2022
|